Corticosteroid Versus Ozone Injections in Chronic Plantar Fasciitis: A Comparative Clinical Study
Abstract
Objective: Plantar fasciitis is a common degenerative condition causing chronic heel pain and functional limitation. Corticosteroid injections are widely used but carry potential adverse effects, whereas ozone therapy has emerged as an alternative with anti-inflammatory and regenerative properties.The aim of this study is to compare the efficacy of ultrasound-guided corticosteroid and ozone injections on pain, function, and quality of life in chronic plantar fasciitis.
Methods: This retrospective cohort study included 59 patients unresponsive to conservative treatment. Patients received either a single corticosteroid injection (Group S, n=30) or three weekly ozone injections (Group O, n=29). Outcomes were assessed using the Numerical Rating Scale (NRS), Foot Function Index (FFI), and Short Form-12 (SF-12) at baseline, 1 month, and 3 months. Treatment response was defined as ≥50% reduction in NRS.
Results: Both groups showed significant improvement over time (p<0.001). Pain reduction was similar at 1 month. At 3 months, corticosteroids resulted in lower NRS scores (p=0.024) and higher responder rates (70.0% vs. 31.0%, p=0.003). Corticosteroids provided greater short-term functional improvement, whereas ozone showed superior FFI scores at 3 months (p<0.001). SF-12 physical scores improved similarly; mental scores favored corticosteroids (p=0.025). No serious adverse events occurred.
Conclusions: Both injections effectively improve pain, function, and quality of life in plantar fasciitis. Corticosteroids provide superior pain relief, while ozone may offer better long-term functional improvement. Treatment selection should be individualized based on clinical priorities.
Keywords
Project Number
Ethical Statement
References
- Lemont H, Ammirati KM, Usen N. Plantar fasciitis: a degenerative process (fasciosis) without inflammation. J Am Podiatr Med Assoc. 2003 May-Jun;93(3):234-7. doi:10.7547/87507315-93-3-234.
- Liebmann K, Kimbrough DW, Best TM, Kouroupis D, Rodriguez Materon S. Plantar fasciitis pathophysiology and the potential role of mesenchymal stem cell-derived extracellular vesicles as therapy. Biomedicines. 2025 Jun 23;13(7):1528. doi:10.3390/biomedicines13071528.
- Nahin RL. Prevalence and pharmaceutical treatment of plantar fasciitis in united states adults. J Pain. 2018 Aug;19(8):885-96. doi:10.1016/j.jpain.2018.03.003.
- Hansen L, Krogh TP, Ellingsen T, Bolvig L, Fredberg U. Long-term prognosis of plantar fasciitis: a 5- to 15-year follow-up study of 174 patients with ultrasound examination. Orthop J Sports Med. 2018 Mar 6;6(3):2325967118757983. doi:10.1177/2325967118757983.
- Tseng WC, Chen YC, Lee TM, Chen WS. Plantar fasciitis: an updated review. J Med Ultrasound. 2023 Oct 6;31(4):268-74. doi:10.4103/jmu.jmu_2_23.
- Goff JD, Crawford R. Diagnosis and treatment of plantar fasciitis. Am Fam Physician. 2011 Sep 15;84(6):676-82.
- Thomas JL, Christensen JC, Kravitz SR, Mendicino RW, Schuberth JM, Vanore JV, et al. The diagnosis and treatment of heel pain: a clinical practice guideline-revision 2010. J Foot Ankle Surg. 2010 May-Jun;49(3 Suppl):S1-19. doi:10.1053/j.jfas.2010.01.001.
- Guimarães JS, Arcanjo FL, Leporace G, Metsavaht LF, Conceição CS, Moreno MVMG, et al. Effects of therapeutic interventions on pain due to plantar fasciitis: a systematic review and meta-analysis. Clin Rehabil. 2023 Jun;37(6):727-46. doi:10.1177/02692155221143865.
Details
Primary Language
English
Subjects
Pain
Journal Section
Research Article
Early Pub Date
August 25, 2026
Publication Date
September 30, 2026
Submission Date
May 4, 2026
Acceptance Date
June 12, 2026
Published in Issue
Year 2026 Volume: 16 Number: 3